Role of focal salvage ablative therapy in localised radiorecurrent prostate cancer.
World J Urol
; 31(6): 1361-8, 2013 Dec.
Article
in En
| MEDLINE
| ID: mdl-24121817
ABSTRACT
Up to one-third of men can fail radical external beam radiotherapy for primary prostate cancer. Most of these men have expectant management with delayed hormones. However, around half of these men have localised recurrence. Challenges remain in identifying such men accurately, in order to enable them to undergo local salvage therapy which is potentially curative. Currently, this includes radical prostatectomy, brachytherapy and ablative whole-gland therapies, such as cryotherapy and high intensity focused ultrasound, all of which can carry significant morbidity. New approaches may involve targeting the area of recurrence alone--focal salvage therapy--in order to reduce tissue damage and thus reduce morbidity. This requires accurate localisation of intraprostatic recurrent disease and precision targeted ablation.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Prostatic Neoplasms
/
Radiotherapy
/
Salvage Therapy
/
Neoplasm Recurrence, Local
Limits:
Humans
/
Male
Language:
En
Journal:
World J Urol
Year:
2013
Document type:
Article
Publication country:
ALEMANHA
/
ALEMANIA
/
DE
/
DEUSTCHLAND
/
GERMANY